IL108856A - Hydroxymethyl furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them - Google Patents
Hydroxymethyl furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL108856A IL108856A IL108856A IL10885694A IL108856A IL 108856 A IL108856 A IL 108856A IL 108856 A IL108856 A IL 108856A IL 10885694 A IL10885694 A IL 10885694A IL 108856 A IL108856 A IL 108856A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- amino
- once
- cycloalkyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4307105A DE4307105A1 (de) | 1993-03-06 | 1993-03-06 | Hydroxymethylfurazancarbonsäurederivate |
Publications (2)
Publication Number | Publication Date |
---|---|
IL108856A0 IL108856A0 (en) | 1994-06-24 |
IL108856A true IL108856A (en) | 1997-07-13 |
Family
ID=6482135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL108856A IL108856A (en) | 1993-03-06 | 1994-03-04 | Hydroxymethyl furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them |
Country Status (21)
Country | Link |
---|---|
US (1) | US5486531A (xx) |
EP (1) | EP0687256B1 (xx) |
JP (1) | JP3578456B2 (xx) |
KR (1) | KR960701029A (xx) |
CN (1) | CN1043140C (xx) |
AT (1) | ATE157660T1 (xx) |
AU (1) | AU676718B2 (xx) |
CA (1) | CA2155840C (xx) |
CZ (1) | CZ284264B6 (xx) |
DE (2) | DE4307105A1 (xx) |
DK (1) | DK0687256T3 (xx) |
ES (1) | ES2108977T3 (xx) |
FI (1) | FI954138L (xx) |
GR (1) | GR3024928T3 (xx) |
HU (1) | HUT72641A (xx) |
IL (1) | IL108856A (xx) |
PL (1) | PL177603B1 (xx) |
RU (1) | RU2134687C1 (xx) |
SK (1) | SK280354B6 (xx) |
WO (1) | WO1994020478A1 (xx) |
ZA (1) | ZA941533B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4401150A1 (de) * | 1994-01-17 | 1995-07-20 | Cassella Ag | Furazancarbonsäurederivate |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
CN100434428C (zh) * | 2003-05-23 | 2008-11-19 | 巴斯利尔药物股份公司 | 呋咱并苯并咪唑类化合物 |
US8822509B2 (en) | 2006-12-29 | 2014-09-02 | The University Of Queensland | Pain-relieving compositions and uses therefor |
CN112125865B (zh) * | 2020-09-30 | 2022-08-12 | 北京理工大学 | 氧化呋咱化合物的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3012862A1 (de) * | 1980-04-02 | 1981-10-08 | Cassella Ag, 6000 Frankfurt | Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel |
DE3047730A1 (de) * | 1980-12-18 | 1982-07-15 | Cassella Ag, 6000 Frankfurt | 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen |
-
1993
- 1993-03-06 DE DE4307105A patent/DE4307105A1/de not_active Withdrawn
-
1994
- 1994-02-18 CZ CZ952281A patent/CZ284264B6/cs not_active IP Right Cessation
- 1994-02-18 PL PL94310655A patent/PL177603B1/pl unknown
- 1994-02-18 JP JP51951094A patent/JP3578456B2/ja not_active Expired - Fee Related
- 1994-02-18 WO PCT/EP1994/000459 patent/WO1994020478A1/de active IP Right Grant
- 1994-02-18 EP EP94908337A patent/EP0687256B1/de not_active Expired - Lifetime
- 1994-02-18 AT AT94908337T patent/ATE157660T1/de not_active IP Right Cessation
- 1994-02-18 CA CA002155840A patent/CA2155840C/en not_active Expired - Fee Related
- 1994-02-18 DE DE59403966T patent/DE59403966D1/de not_active Expired - Lifetime
- 1994-02-18 DK DK94908337.2T patent/DK0687256T3/da active
- 1994-02-18 RU RU95118170A patent/RU2134687C1/ru active
- 1994-02-18 CN CN94191395A patent/CN1043140C/zh not_active Expired - Fee Related
- 1994-02-18 KR KR1019950703761A patent/KR960701029A/ko not_active Ceased
- 1994-02-18 AU AU61414/94A patent/AU676718B2/en not_active Ceased
- 1994-02-18 SK SK1110-95A patent/SK280354B6/sk unknown
- 1994-02-18 ES ES94908337T patent/ES2108977T3/es not_active Expired - Lifetime
- 1994-02-18 HU HU9502603A patent/HUT72641A/hu unknown
- 1994-03-04 ZA ZA941533A patent/ZA941533B/xx unknown
- 1994-03-04 IL IL108856A patent/IL108856A/xx active IP Right Grant
- 1994-03-07 US US08/207,280 patent/US5486531A/en not_active Expired - Lifetime
-
1995
- 1995-09-04 FI FI954138A patent/FI954138L/fi unknown
-
1997
- 1997-10-03 GR GR970402569T patent/GR3024928T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE157660T1 (de) | 1997-09-15 |
GR3024928T3 (en) | 1998-01-30 |
KR960701029A (ko) | 1996-02-24 |
EP0687256B1 (de) | 1997-09-03 |
CZ284264B6 (cs) | 1998-10-14 |
HUT72641A (en) | 1996-05-28 |
JP3578456B2 (ja) | 2004-10-20 |
CA2155840A1 (en) | 1994-09-15 |
AU6141494A (en) | 1994-09-26 |
DE4307105A1 (de) | 1994-09-08 |
SK110095A3 (en) | 1996-01-10 |
DK0687256T3 (da) | 1998-03-30 |
SK280354B6 (sk) | 1999-12-10 |
DE59403966D1 (de) | 1997-10-09 |
JPH08507299A (ja) | 1996-08-06 |
CA2155840C (en) | 2005-05-24 |
EP0687256A1 (de) | 1995-12-20 |
CN1119013A (zh) | 1996-03-20 |
FI954138A0 (fi) | 1995-09-04 |
PL177603B1 (pl) | 1999-12-31 |
IL108856A0 (en) | 1994-06-24 |
WO1994020478A1 (de) | 1994-09-15 |
CN1043140C (zh) | 1999-04-28 |
HU9502603D0 (en) | 1995-11-28 |
FI954138L (fi) | 1995-09-04 |
RU2134687C1 (ru) | 1999-08-20 |
AU676718B2 (en) | 1997-03-20 |
US5486531A (en) | 1996-01-23 |
ES2108977T3 (es) | 1998-01-01 |
CZ228195A3 (en) | 1995-12-13 |
ZA941533B (en) | 1994-10-06 |
PL310655A1 (en) | 1995-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9218322D0 (en) | Therapeutic agents | |
GB9126260D0 (en) | Therapeutic agents | |
DE69720965D1 (de) | Chinazolinderivate und deren verwendung als vegf hemmer | |
TW369526B (en) | Diazabicyclic neurokinin antagonists | |
TW358096B (en) | Pyrazolopyridimidinone antianginal agents | |
IL108856A (en) | Hydroxymethyl furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
IL102383A0 (en) | Methylene-oxindole derivatives,their preparation and pharmaceutical compositions containing them | |
MY117803A (en) | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
WO1994022829A3 (en) | Dihydropyridines and new uses thereof | |
HUT60733A (en) | Process for producing new n-(4-piperidinyl)-(dihydrobenzofuran or dihydro-2h-benzopyran)-carboxamide derivatives and pharmaceutical compositions comprising such compounds | |
ES8404330A1 (es) | Un metodo para la produccion de derivados de esteres de acidos 1,4-dihidropiridin-3,5-dicarboxilicos. | |
MY119623A (en) | Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia | |
AU2190895A (en) | Amidino derivatives useful as nitric oxide synthase inhibitors | |
HUT60271A (en) | Process for producing tricyclic compounds, functioning as enzyme inhibitior and comprising amino or nitro group and pharmaceutical compositions comprising same as active ingredient | |
SE9701304D0 (sv) | Compounds | |
GEP19960657B (en) | Oxadiazole-alkyl-purine derivatives useful as antitussive agents | |
MY129176A (en) | Tetrahydro gamma-carbolines | |
AU1065592A (en) | Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
BR9307091A (pt) | Acido benzenoalcanóicos para doenças cardiovasculares | |
ATE42747T1 (de) | N-(2-(tetrahydro-3,5-dioxo-1h-pyrrolizin-7a(5h) yl)ethyl>aminderivate. | |
DE69503905D1 (de) | Peptidderivate mit metallopeptidasehemmender aktivität | |
NZ505110A (en) | Neuroprotective agents | |
NO954764L (no) | Psoralen-derivater, deres fremstilling og anvendelse | |
ES8103086A1 (es) | Procedimiento de preparacion de nuevos derivados pirido (2,3-e)-as-triazinos y de sus sales de adicion acidas | |
CA2186224A1 (en) | Amidino derivatives useful as nitric oxide synthase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |